Delivery Order SPE2DR25D3301-SPE2DR26F18EX
- Not listed
- The Defense Logistics Agency awarded a $1,718.48 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg on September 24, 2025, with an ultimate completion date of October 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,711.94 to AmerisourceBergen Drug Corp for the supply of Envarsus XR 4 mg tablets (100-count) on October 21, 2025, with completion targeted for November 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Envarsus XR 1 mg tablets (30-count packages) with a ceiling value of $1,553.40. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 4, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Envarsus XR 1 mg tablets in a quantity of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,718.48 with firm fixed pricing and is scheduled for completion by September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Envarsus XR 4 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order valued at $5,412.39, with performance to be completed by December 5, 2025, at the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Envarsus XR 0.75 mg tablets (100 count) with a ceiling value of $2,037.96 and a firm fixed price structure. This delivery order is non-competitive and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Envarsus XR 1 mg tablets in a quantity of 100s, with a ceiling value of $1,718.48 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract that will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 15, 2025. The delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on May 8, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Envarsus XR 1 mg tablets (30-count) at a ceiling value of $1,553.40. The contract is a firm fixed-price delivery order with an ultimate completion date of May 30, 2025, and was competitively awarded without set-aside designation. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,274.08 to AmerisourceBergen Drug Corp for the supply of Envarsus XR 1 mg tablets (30-count) on November 12, 2025, with completion scheduled for December 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 vehicle running...
- The Defense Logistics Agency has awarded a delivery order valued at $1,711.95 to AmerisourceBergen Drug Corp for the supply of Envarsus XR 4 mg tablets (100-count packaging). This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by October 21, 2025. The contract will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania, where AmerisourceBergen maintains operations as a primary pharmaceutical...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18EXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,358.64 to AmerisourceBergen Drug Corp for the supply of Envarsus XR 0.75 mg tablets (100 count) on November 18, 2025, with an ultimate completion date of December 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As the prime contractor under the comprehensive DLA Troop Support Medical IDC, the company supplies a broad portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Envarsus XR, an immunosuppressant medication, exemplifies the company's role in fulfilling pharmaceutical supply requirements across the federal healthcare enterprise through flexible contract mechanisms designed to support global military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/18/25 |